Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2005
08/03/2005EP1558616A2 Meso-substituted porphyrins
08/03/2005EP1558613A2 Pre-organized tricyclic integrase inhibitor compounds
08/03/2005EP1558600A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558586A2 Inhibitors of akt activity
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558248A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
08/03/2005EP1357124B1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
08/03/2005EP1123293B1 Core-extended perylene bisimides
08/03/2005CN1649967A Method for the production of perylen-3, 4:9, 10-tetracarboxylic acid diimides and perylen-3, 4:9, 10-tetracarboxylic acid dianhydride and naphtalene-1, 8-dicarboxylimides
08/03/2005CN1649872A Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines
08/03/2005CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones
08/03/2005CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues
08/03/2005CN1648128A Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine
08/03/2005CN1213048C Heterocyclic compound 2-aminoimidazopyrrole-6-one and its preparing method and use
08/03/2005CN1213036C Novel amide derivatives
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924282 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids
08/02/2005US6924280 Dipeptide derivatives
08/02/2005US6923835 Hair dyes comprising heterocyclic amines such as N,N'-bis[1-(4-aminophenyl)pyrrolidin-3-yl]-N,N,N',N'-tetramethylhexane-1,6-diaminium dichloride having colorfastness and chemical resistance
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2154577C Novel inhibitors of adenosine monophosphate deaminase
07/2005
07/28/2005WO2005068483A1 Metal complexes having vitamin b12 as a ligand
07/28/2005WO2005068469A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12]urils
07/28/2005WO2005068467A1 Novel fused-ring compound
07/28/2005WO2005068466A1 Compounds useful in therapy
07/28/2005WO2005067936A2 Methods for the production of sildenafil base and citrate salt
07/28/2005WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/28/2005WO2005067546A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
07/28/2005WO2005054246A3 Amine derivatives having a tyrosine-kinase-inhibiting effect
07/28/2005WO2005051953A3 Pyrrolo-pyrazine derivatives useful as cb1-modulators
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005WO2005047287A3 Bicyclic pyrazolone cytokine inhibitors
07/28/2005WO2005034838A3 Protease inhibitors
07/28/2005WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
07/28/2005WO2004093828A3 Reverse-turn mimetics and method relating thereto
07/28/2005WO2002096905A8 Thiazole compounds useful as inhibitors of protein kinases
07/28/2005US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165029 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
07/28/2005US20050165027 Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005US20050165023 Imidazo-triazine derivatives as ligands for gaba receptors
07/28/2005US20050165007 Benzimidazoles and analogs thereof as antivirals
07/28/2005US20050165005 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005US20050164029 Reactive dendrimers
07/28/2005DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
07/28/2005DE10359098A1 Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel New 2- (piperazin-1-yl) - and 2 - ([1,4] diazepan-1-yl) -imidazo [4,5-d] pyridazin-4-ones, their preparation and their use as medicaments
07/28/2005CA2554382A1 Compounds useful in therapy
07/28/2005CA2553329A1 New fused polycyclic compounds
07/28/2005CA2552916A1 Metal complexes having vitamin b12 as a ligand
07/28/2005CA2552027A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12]urils
07/28/2005CA2552003A1 Methods for the production of sildenafil base and citrate salt
07/28/2005CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/28/2005CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof
07/27/2005EP1557418A1 Novel quinoxaline derivatives
07/27/2005EP1557417A1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2a] pyrimidin-6-one derivatives
07/27/2005EP1557409A1 5HT2C receptor modulators
07/27/2005EP1557168A2 Biarylurea Derivatives
07/27/2005EP1556385A1 Heterocyclocarboxamide derivatives
07/27/2005EP1556384A2 Pyrimido compounds having antiproliferative activity
07/27/2005EP1556381A1 Pyrazole amides for treating hiv infections
07/27/2005EP1556348A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
07/27/2005EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy
07/27/2005EP1351961B1 Substituted indolines as 5-ht receptor ligands
07/27/2005EP1313736B1 Condensed pyrazindione derivatives as inhibitors of pde5
07/27/2005EP1277754B1 Imidazopyridine derivatives
07/27/2005EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors
07/27/2005EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction
07/27/2005CN1646535A Pyrrolopyrimidine derivative
07/27/2005CN1646533A 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1, 2-a]pyrimidin-5(1H)-one derivatives
07/27/2005CN1646529A Imidazo fused compounds
07/27/2005CN1646502A Triazole derivatives as tachykinin receptor antagonists
07/27/2005CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
07/27/2005CN1646493A 5HT2C receptor modulators
07/27/2005CN1646131A Novel compounds
07/27/2005CN1212317C Novel ester or amide derivatives
07/26/2005US6921825 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia
07/26/2005US6921823 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
07/26/2005US6921763 Protein kinase inhibitors
07/26/2005US6921762 Substituted indolizine-like compounds and methods of use
07/26/2005US6921760 Psychotherapeutic agents.
07/26/2005US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV
07/26/2005CA2258548C Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
07/21/2005WO2005066184A1 Novel indeno[2,1a]indenes and isoindol[2,1-a]indoles
07/21/2005WO2005066179A1 Method for preparing phthalocyanines
07/21/2005WO2005066178A1 Triaza-cyclopenta[cd]indene derivatives
07/21/2005WO2005066177A1 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
07/21/2005WO2005066176A1 Pyrrolotriazine compounds as kinase inhibitors
07/21/2005WO2005066174A2 Process for the preparation of carbapenem compounds
07/21/2005WO2005066171A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
07/21/2005WO2005066142A2 Pyrrolopyrimidine and pyrrolotriazine derivatives as crf receptor antagonists
07/21/2005WO2005065416A2 Process for the preparation of pyridopyrimidones
07/21/2005WO2005065266A2 Di-substituted pyrrolotriazine compounds